1. Home
  2. ABEO vs WILC Comparison

ABEO vs WILC Comparison

Compare ABEO & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • WILC
  • Stock Information
  • Founded
  • ABEO 1974
  • WILC 1994
  • Country
  • ABEO United States
  • WILC Israel
  • Employees
  • ABEO N/A
  • WILC N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • WILC Food Distributors
  • Sector
  • ABEO Health Care
  • WILC Consumer Discretionary
  • Exchange
  • ABEO Nasdaq
  • WILC Nasdaq
  • Market Cap
  • ABEO 256.9M
  • WILC 271.3M
  • IPO Year
  • ABEO 1980
  • WILC 1997
  • Fundamental
  • Price
  • ABEO $6.59
  • WILC $19.57
  • Analyst Decision
  • ABEO Strong Buy
  • WILC
  • Analyst Count
  • ABEO 6
  • WILC 0
  • Target Price
  • ABEO $18.00
  • WILC N/A
  • AVG Volume (30 Days)
  • ABEO 1.2M
  • WILC 31.6K
  • Earning Date
  • ABEO 08-11-2025
  • WILC 08-12-2025
  • Dividend Yield
  • ABEO N/A
  • WILC 4.92%
  • EPS Growth
  • ABEO N/A
  • WILC 80.33
  • EPS
  • ABEO N/A
  • WILC 1.37
  • Revenue
  • ABEO N/A
  • WILC $157,003,357.00
  • Revenue This Year
  • ABEO N/A
  • WILC N/A
  • Revenue Next Year
  • ABEO $322.37
  • WILC N/A
  • P/E Ratio
  • ABEO N/A
  • WILC $14.51
  • Revenue Growth
  • ABEO N/A
  • WILC 10.73
  • 52 Week Low
  • ABEO $3.93
  • WILC $9.04
  • 52 Week High
  • ABEO $7.32
  • WILC $20.32
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 66.16
  • WILC 69.34
  • Support Level
  • ABEO $5.66
  • WILC $19.55
  • Resistance Level
  • ABEO $5.99
  • WILC $20.26
  • Average True Range (ATR)
  • ABEO 0.26
  • WILC 0.50
  • MACD
  • ABEO 0.09
  • WILC 0.02
  • Stochastic Oscillator
  • ABEO 76.92
  • WILC 80.76

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, with one segment Import-export, marketing, and distribution of food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

Share on Social Networks: